Erythroferrone inhibits the induction of hepcidin by BMP6

Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization

Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803

Dysmetabolic Hyperferritinemia: All Iron Overload Is Not Hemochromatosis

Makker, J. S., Hanif, A., Bajantri, B., & Chilimuri, S. S. (2015) · Case Reports in Gastroenterology · doi:10.1159/000373883 · Cited by 1,353

Identification of erythroferrone as an erythroid regulator of iron metabolism

Kautz, L., Jung, G., Valore, E. V., Rivella, S., Nemeth, E., & Ganz, T. (2014) · Nature Genetics · doi:10.1038/ng.2996 · Cited by 1,127

Hepcidin and iron regulation, 10 years later

Ganz, T. (2011) · Blood · doi:10.1182/blood-2011-01-258467 · Cited by 962

Identification and Functional Characterization of Distinct Critically Important Bone Morphogenetic Protein-specific Response Elements in the Id1 Promoter

Korchynskyi, O., & ten Dijke, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111023200 · Cited by 876

BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism

Andriopoulos Jr, B., Corradini, E., Xia, Y., Faasse, S. A., Chen, S., Grgurevic, L., Knutson, M. D., Pietrangelo, A., Vukicevic, S., Lin, H. Y., et al. (2009) · Nature Genetics · doi:10.1038/ng.335 · Cited by 769

Lack of the bone morphogenetic protein BMP6 induces massive iron overload

Meynard, D., Kautz, L., Darnaud, V., Canonne-Hergaux, F., Coppin, H., & Roth, M.-P. (2009) · Nature Genetics · doi:10.1038/ng.320 · Cited by 587

Suppression of hepcidin during anemia requires erythropoietic activity

Pak, M., Lopez, M. A., Gabayan, V., Ganz, T., & Rivera, S. (2006) · Blood · doi:10.1182/blood-2006-06-028787 · Cited by 472

Structure–activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors

Cuny, G. D., Yu, P. B., Laha, J. K., Xing, X., Liu, J.-F., Lai, C. S. C., Deng, D. Y., Sachidanandan, C., Bloch, K. D., & Peterson, R. T. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.06.052 · Cited by 351

Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin

Aschemeyer, S., Qiao, B., Stefanova, D., Valore, E. V., Sek, A. C., Ruwe, T. A., Vieth, K. R., Jung, G., Casu, C., Rivella, S., et al. (2018) · Blood · doi:10.1182/blood-2017-05-786590 · Cited by 325

Erythroferrone exacerbates iron overload and ineffective extramedullary erythropoiesis in a mouse model of β-thalassemia

Olivera, J. D., Zhang, V., Nemeth, E., & Ganz, T. (2023) · Blood Advances · doi:10.1182/bloodadvances.2022009307 · Cited by 25

Signaling pathways regulating hepcidin

Rishi, G., & Subramaniam, V. N. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2019.01.003 · Cited by 23

Inherited microcytic anemias

Cappellini, M. D., Russo, R., Andolfo, I., & Iolascon, A. (2020) · Hematology · doi:10.1182/hematology.2020000158 · Cited by 26

Advances of Iron and Ferroptosis in Diabetic Kidney Disease

Chu, J., Wang, K., Lu, L., Zhao, H., Hu, J., Xiao, W., & Wu, Q. (2024) · Kidney International Reports · doi:10.1016/j.ekir.2024.04.012 · Cited by 24

Hepcidin as a therapeutic target in iron overload

Sandnes, M., & Reikvam, H. (2024) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2024.2443081 · Cited by 22

GDF11 contributes to hepatic hepcidin (HAMP) inhibition through SMURF1‐mediated BMP‐SMAD signalling suppression

Fang, Z., Zhu, Z., Zhang, H., Peng, Y., Liu, J., Lu, H., Jiang, L., Liang, L., Xia, S., Wang, Q., et al. (2019) · British Journal of Haematology · doi:10.1111/bjh.16156 · Cited by 23

New diagnostic tools for delineating iron status

Ginzburg, Y. Z. (2019) · Hematology · doi:10.1182/hematology.2019000035 · Cited by 22

Essential role of systemic iron mobilization and redistribution for adaptive thermogenesis through HIF2-α/hepcidin axis

Yook, J., You, M., Kim, J., Toney, A. M., Fan, R., Puniya, B. L., Helikar, T., Vaulont, S., Deschemin, J., Okla, M., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2109186118 · Cited by 21

Renal control of life-threatening malarial anemia

Wu, Q., Sacomboio, E. N. M., de Souza, L. V., Martins, R., Kitoko, J. Z., Cardoso, S., Ademolue, T. W., Paixão, T., Lehtimäki, J. I., Figueiredo, A. L., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112057 · Cited by 20

Safety of HIF prolyl hydroxylase inhibitors for anemia in dialysis patients: a systematic review and network meta-analysis

Chen, D., Niu, Y., Liu, F., Yang, Y., Wang, X., Li, P., & Chen, X. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1163908 · Cited by 24

Anaemia of chronic diseases: Pathophysiology, diagnosis and treatment

Allende, R. D. L. C., de Entresotos, L. D., & Díez, S. C. (2021) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2020.07.022 · Cited by 24

Black pepper prevents anemia of inflammation by inhibiting hepcidin over-expression through BMP6-SMAD1/ IL6-STAT3 signaling pathway

Banerjee, S., Katiyar, P., Kumar, L., Kumar, V., Saini, S. S., Krishnan, V., Sircar, D., & Roy, P. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.03.019 · Cited by 20

Novel potential therapeutics to modify iron metabolism and red cell synthesis in diseases associated with defective erythropoiesis

Guerra, A., Parhiz, H., & Rivella, S. (2023) · Haematologica · doi:10.3324/haematol.2023.283057 · Cited by 19

Anemia of inflammation and iron metabolism in chronic diseases

Díez, S. C., Allende, R. D. L. C., & García, E. C. (2024) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2024.09.002 · Cited by 19

Host and microbiota derived extracellular vesicles: Crucial players in iron homeostasis

Daou, Y., Falabrègue, M., Pourzand, C., Peyssonnaux, C., & Edeas, M. A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.985141 · Cited by 19

The association between growth differentiation factor-15, erythroferrone, and iron status in thalassemic patients

Youssry, I., Samy, R. M., AbdelMohsen, M., & Salama, N. M. (2023) · Pediatric Research · doi:10.1038/s41390-023-02729-5 · Cited by 18

Nutritional Modulation of Hepcidin in the Treatment of Various Anemic States

Dandrea, P., Giampieri, F., & Battino, M. (2023) · Nutrients · doi:10.3390/nu15245081 · Cited by 16

Erythropoiesis and Iron Homeostasis in Non-Transfusion-Dependent Thalassemia Patients with Extramedullary Hematopoiesis

Huang, Y., Liu, R., Wei, X., Liu, J., Pan, L., Yang, G., & Lai, Y. (2019) · BioMed Research International · doi:10.1155/2019/4504302 · Cited by 18

Iron status in late pregnancy is inversely associated with birth weight in Colombia

Puerto, A., Trojan, A., Alvis-Zakzuk, N. R., Sáleme, R. L., Edna-Estrada, F., Alvarez, A., Alvis‐Guzmán, N., & Zakzuk, J. (2021) · Public Health Nutrition · doi:10.1017/s136898002100166x · Cited by 18

Emerging Pathogenetic Mechanisms and New Drugs for Anemia in Myelofibrosis and Myelodysplastic Syndromes

Gangat, N., & Tefferi, A. (2025) · American Journal of Hematology · doi:10.1002/ajh.27659 · Cited by 18

The Emerging Role of Ferroptosis in Liver Cancers

Casini, A., Leone, S., Vaccaro, R., Vivacqua, G., Ceci, L., Pannarale, L., Franchitto, A., Onori, P., Gaudio, E., & Mancinelli, R. (2022) · Life · doi:10.3390/life12122128 · Cited by 17

Serum Levels of Myonectin Are Lower in Adults with Metabolic Syndrome and Are Negatively Correlated with Android Fat Mass

Petro, J. L., Fragozo-Ramos, M. C., Milán, A. F., Aristizábal, J. C., Gallo‐Villegas, J., & Calderón, J. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24086874 · Cited by 17

Iron Deficiency Anemia

Li, X., & Finberg, K. E. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-92033-2_12 · Cited by 17

Molecular Mechanisms of Iron Metabolism and Overload

Tayal, A., Kaur, J., Sadeghi, P., & Maitta, R. W. (2025) · Biomedicines · doi:10.3390/biomedicines13092067 · Cited by 24

Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplant

Pirotte, M., Fillet, M., Seidel, L., Jaspers, A., Baron, F., & Beguin, Y. P. (2021) · American Journal of Hematology · doi:10.1002/ajh.26300 · Cited by 16

Erythroferrone in focus: emerging perspectives in iron metabolism and hematopathologies

Babar, S., & Saboor, M. (2024) · Blood Science · doi:10.1097/bs9.0000000000000198 · Cited by 17

The Interplay between Drivers of Erythropoiesis and Iron Homeostasis in Rare Hereditary Anemias: Tipping the Balance

Grootendorst, S. T., de Wilde, J. R. A., van Dooijeweert, B., van Vuren, A. J., van Solinge, W. W., Schutgens, R. E. G., van Wijk, R., & Bartels, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042204 · Cited by 16

Tackling the unknowns in understanding and management of hospital acquired anemia

Bressman, E., Jhang, J. S., McClaskey, J. H., & Ginzburg, Y. Z. (2021) · Blood Reviews · doi:10.1016/j.blre.2021.100830 · Cited by 18

Effects of green tea extract treatment on erythropoiesis and iron parameters in iron-overloaded β-thalassemic mice

Settakorn, K., Kongkarnka, S., Chompupoung, A., Svasti, S., Fucharoen, S., Porter, J. B., Srichairatanakool, S., & Koonyosying, P. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1053060 · Cited by 14

Activation of Intestinal HIF2α Ameliorates Iron‐Refractory Anemia

Yu, Y., Su, Y., Yang, S., Liu, Y., Lin, Z., Das, N. K., Wu, Q., Zhou, J., Sun, S., Li, X., et al. (2024) · Advanced Science · doi:10.1002/advs.202307022 · Cited by 14

Iron and erythropoiesis: A mutual alliance

Silvestri, L., & Nai, A. (2021) · Seminars in Hematology · doi:10.1053/j.seminhematol.2021.05.002 · Cited by 16

Direct modulation of hepatocyte hepcidin signaling by iron

Yu, L., Wang, S., Chen, C., Rausch, V., Elshaarawy, O., & Mueller, S. (2021) · World Journal of Hepatology · doi:10.4254/wjh.v13.i10.1378 · Cited by 15

Protein Modifications Critical for Myonectin/Erythroferrone Secretion and Oligomer Assembly

Stewart, A. N., Little, H. C., Clark, D. J., Zhang, H., & Wong, G. W. (2020) · Biochemistry · doi:10.1021/acs.biochem.0c00461 · Cited by 14

Iron metabolism disorder regulated by BMP signaling in hypoxic pulmonary hypertension

Jiang, Y., Guo, Y., Feng, X., Yang, P., Liu, Y., Dai, X., Zhao, F., Lei, D., Li, X., Liu, Y., et al. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166589 · Cited by 12

Hepcidin and its multiple partners: Complex regulation of iron metabolism in health and disease

Ginzburg, Y. Z. (2023) · Vitamins and hormones · doi:10.1016/bs.vh.2023.03.001 · Cited by 15

Mitapivat improves ineffective erythropoiesis and iron overload in adult patients with pyruvate kinase deficiency

van Beers, E. J., Al-Samkari, H. T., Grace, R. F., Barcellini, W., Glenthøj, A. B., DiBacco, M. L., Wind‐Rotolo, M., Xu, R., Beynon, V., Patel, P., et al. (2024) · Blood Advances · doi:10.1182/bloodadvances.2023011743 · Cited by 12

Evaluation of Erythroferrone, Hepcidin, and Iron Overload Status in Iraqi Transfusion-Dependent β-Thalassemia Major Patients

Smesam, H. N., Albuthabhak, H. A. Q., Arjmand, S., Al‐Hakeim, H. K., & Siadat, S. O. R. (2020) · Hemoglobin · doi:10.1080/03630269.2020.1794888 · Cited by 13

A role for hepcidin in the anemia caused by Trypanosoma brucei infection

Neves, J. V., Gomes, A. C., Costa, D. M., Barroso, C., Vaulont, S., Cordeiro‐da‐Silva, A., Tavares, J., & Rodrigues, P. (2020) · Haematologica · doi:10.3324/haematol.2019.227728 · Cited by 13

SEC23B Loss-of-Function Suppresses Hepcidin Expression by Impairing Glycosylation Pathway in Human Hepatic Cells

Rosato, B. E., Marra, R., D’Onofrio, V., Giudice, F. D., Monica, S. D., Iolascon, A., Andolfo, I., & Russo, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031304 · Cited by 13

Pathogenic Mechanisms in Thalassemia II

Ganz, T., & Nemeth, E. (2023) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.12.006 · Cited by 17

Disordered serum erythroferrone and hepcidin levels as indicators of the spontaneous abortion occurrence during early pregnancy in humans

Wei, S., Liu, W., Qi, Y., Guo, Y., Zhang, S., Wang, L., Zhuang, T., Zhang, N., & Liu, S. (2020) · British Journal of Haematology · doi:10.1111/bjh.17049 · Cited by 14

Relationship between iron overload caused by abnormal hepcidin expression and liver disease: A review

Zheng, H., Yang, F., Deng, K., Wei, J., Liu, Z., Zheng, Y., & Xu, H. (2023) · Medicine · doi:10.1097/md.0000000000033225 · Cited by 12

FK506 bypasses the effect of erythroferrone in cancer cachexia skeletal muscle atrophy

Mina, E., Wyart, E., Sartori, R., Angelino, E., Zaggia, I., Rausch, V., Maldotti, M., Pagani, A., Hsu, M. Y., Friziero, A., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101306 · Cited by 13

To induce or not to induce: the fight over hepcidin regulation

Sangkhae, V., & Nemeth, E. (2019) · Haematologica · doi:10.3324/haematol.2019.216960 · Cited by 12

Erythropoiesis and Iron Parameters in Transfusion-dependent and Nontransfusion-dependent Thalassemias

Öztürk, Z., Gümüşlü, S., Yalçın, K., & Küpesiz, A. (2020) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000002046 · Cited by 13

Hypobaric hypoxia induces iron mobilization from liver and spleen and increases serum iron via activation of ghrelin/GHSR1a/MAPK signalling pathway in mice

Yang, W.-P., Li, J., Hu, J., Yuan, X., Ding, J., Jiang, H., Wang, G., & Luo, Q. (2023) · Scientific Reports · doi:10.1038/s41598-023-47596-6 · Cited by 10

Iron homeostasis governs erythroid phenotype in Polycythemia Vera

Bennett, C., Jackson, V. E., Pettikiriarachchi, A., Hayman, T., Schaeper, U., Moir-Meyer, G., Fielding, K., Ataíde, R., Clucas, D. B., Baldi, A., et al. (2023) · Blood · doi:10.1182/blood.2022016779 · Cited by 13

Erythroferrone in iron regulation and beyond

Babitt, J. L. (2022) · Blood · doi:10.1182/blood.2021014326 · Cited by 12

Current Landscape of Hepcidin Therapeutics

Nai, A., Silvestri, L., Asperti, M., & Vinchi, F. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-92033-2_26 · Cited by 11

Chronic intermittent hypobaric hypoxia improves iron metabolism disorders via the IL-6/JAK2/STAT3 and Epo/STAT5/ERFE signaling pathways in metabolic syndrome rats

Cui, F., Sun, J. Y., Mi, H., Li, B., Tang, L., Wang, R., Du, Y., Guo, B., Li, Y., & Shi, M. (2023) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2023.127259 · Cited by 11

A randomized placebo−controlled clinical trial of oral green tea epigallocatechin 3−gallate on erythropoiesis and oxidative stress in transfusion−dependent β−thalassemia patients

Settakorn, K., Hantrakool, S., Petiwathayakorn, T., Hutachok, N., Tantiworawit, A., Charoenkwan, P., Chalortham, N., Chompupoung, A., Paradee, N., Koonyosying, P., et al. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1248742 · Cited by 13

The EHA Research Roadmap: Anemias

Iolascon, A., Rivella, S., Anagnou, N. P., Camaschella, C., Swinkels, D. W., Muckenthaler, M. U., Porto, G., Barcellini, W., Andolfo, I., Risitano, A. M., et al. (2021) · HemaSphere · doi:10.1097/hs9.0000000000000607 · Cited by 11

Ferroptosis in cardiovascular diseases: molecular mechanisms and a novel therapeutic target

Yu, S., Pang, Z., Fang, H., & Liu, C. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00420-9 · Cited by 13

Low Serum Hepcidin Levels in Patients with Ulcerative Colitis – Implications for Treatment of Co-existent Iron-Deficiency Anemia

Ramasamy, J., Jagadish, C., Sukumaran, A., Varghese, J., Mani, T., Joseph, A. J., Simon, E. G., & Jacob, M. (2023) · Inflammation · doi:10.1007/s10753-023-01872-9 · Cited by 11

Stabilizing Hypoxia-Inducible Factor to Manage Anemia in Chronic Kidney Disease: From Basic Theory to Clinical Study

Wang, Y., & Yu, X. (2024) · Kidney Diseases · doi:10.1159/000536039 · Cited by 14

Proton pump inhibition for secondary hemochromatosis in hereditary anemia: a phase III placebo‐controlled randomized cross‐over clinical trial

van Vuren, A. J., Kerkhoffs, J., Schols, S. E. M., Rijneveld, A. W., Nur, E., Peereboom, D., Gandon, Y., Welsing, P. M. J., van Wijk, R., Schutgens, R. E. G., et al. (2022) · American Journal of Hematology · doi:10.1002/ajh.26581 · Cited by 9

Disorders of Iron Metabolism

Cappellini, M. D. (2022) · Springer eBooks · doi:10.1007/978-3-030-67727-5_37 · Cited by 10

Characterization of erythroferrone oligomerization and its impact on BMP antagonism

Mast, E. M., Leach, E. A. E., & Thompson, T. B. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105452 · Cited by 9

An Analysis of AMPK and Ferroptosis in Cancer: A Potential Regulatory Axis

Zhang, T., Wang, X., Alexander, P. G., Feng, P., & Zhang, J. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl36618 · Cited by 12

Matriptase-2 and Hemojuvelin in Hepcidin Regulation: In Vivo Immunoblot Studies in Mask Mice

Krijt, J., Frýdlová, J., Gurieva, I., Přikryl, P., Báječný, M., Steinbicker, A. U., Vokurka, M., & Truksa, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052650 · Cited by 9

Characterization of erythroferrone structural domains relevant to its iron-regulatory function

Srole, D. N., Jung, G., Waring, A. J., Nemeth, E., & Ganz, T. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105374 · Cited by 9

Hookworm infection as a model for deepen knowledge of iron metabolism and erythropoiesis in anemia

Furtado, L. F. V., Alves, W. P., da Silva, V. J., & Rabelo, É. M. L. (2024) · Cytokine · doi:10.1016/j.cyto.2024.156559 · Cited by 10

Combination of a TGF ‐β ligand trap ( RAP‐GRL ) and TMPRSS6 ‐ASO is superior for correcting β‐thalassemia

Guerra, A., Hamilton, N., Rivera, A., Demsko, P., Guo, S., & Rivella, S. (2024) · American Journal of Hematology · doi:10.1002/ajh.27332 · Cited by 9

Fibrinogen‐like 1: A hepatokine linking liver physiology to hematology

Personnaz, J., Guillou, H., & Kautz, L. (2024) · HemaSphere · doi:10.1002/hem3.115 · Cited by 8

Anemia de la inflamación y metabolismo del hierro en las enfermedades crónicas

Díez, S. C., Allende, R. D. L. C., & García, E. C. (2024) · Revista Clínica Española · doi:10.1016/j.rce.2024.06.013 · Cited by 10

New potential players in hepcidin regulation

Chappell, M., & Rivella, S. (2019) · Haematologica · doi:10.3324/haematol.2019.224311 · Cited by 9

Insights into basic science: what basic science can teach us about iron homeostasis in trauma patients

Bartnikas, T. B., Steinbicker, A. U., & Enns, C. A. (2019) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000825 · Cited by 9

EnvIRONmental Aspects in Myelodysplastic Syndrome

Petzer, V., Theurl, I., Weiß, G., & Wolf, D. G. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105202 · Cited by 10

A long sought after “receptor” for ERFE?

Zhang, A., & Enns, C. A. (2018) · Blood · doi:10.1182/blood-2018-08-869586 · Cited by 9

Hto, Tritiated Amino Acid Exposure and External Exposure Induce Differential Effects on Hematopoiesis and Iron Metabolism

Bertho, J., Kereselidze, D., Manens, L., Culeux, C., Magneron, V., Surette, J., Blimkie, M., Bertrand, L., Wyatt, H., Souidi, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-56453-4 · Cited by 12

Iron homeostasis in a mouse model of thalassemia intermedia is altered between adolescence and adulthood

Sanyear, C., Butthep, P., Eamsaard, W., Fucharoen, S., Svasti, S., & Masaratana, P. (2020) · PeerJ · doi:10.7717/peerj.8802 · Cited by 9

Low anticoagulant heparin-iron complex targeting inhibition of hepcidin ameliorates anemia of chronic disease in rodents

Li, L., Wang, X., Zhang, H., Chen, Q., & Cui, H. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173958 · Cited by 9

Molecular insights into placental iron transfer mechanisms and maternofetal regulation

Santhakumar, S., & Edison, E. S. (2023) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-023-07032-6 · Cited by 8

Is iron deficiency caused by BMPR2 mutations or dysfunction in pulmonary arterial hypertension patients?

Theobald, V., Grünig, E., Benjamin, N., Seyfarth, H., Halank, M., Schneider, M. A., Richtmann, S., Kazdal, D. N., Hinderhofer, K., Xanthouli, P., et al. (2023) · Pulmonary Circulation · doi:10.1002/pul2.12242 · Cited by 7

Iron, the Essential Micronutrient: A Comprehensive Review of Regulatory Pathways of Iron Metabolism

Horváth, A., Tamási, K., Pap, R., Jánosa, G., & Pandur, E. (2025) · Nutrients · doi:10.3390/nu18010109 · Cited by 12

Iron parameters in pregnant women with beta‐thalassaemia minor combined with iron deficiency anaemia compared to pregnant women with iron deficiency anaemia alone demonstrate the safety of iron supplementation in beta‐thalassaemia minor during pregnancy

Chen, N., Li, Z., Huang, Y., Xiao, C., Shen, X., Pan, S., Su, Q., & Wang, Z. (2021) · British Journal of Haematology · doi:10.1111/bjh.17827 · Cited by 8

Iron Supplements Concomitant within Hypoxia-Inducible Factor Prolyl Hydroxylase Domain Inhibitors in the Treatment of Chronic Kidney Disease Anemia

Wang, X., Wei, C., Zhao, D., Sun, X., Zhu, F., Mei, Y., Ma, Q., Cai, G., Chen, X., & Li, P. (2023) · Kidney Diseases · doi:10.1159/000533304 · Cited by 8

Erythroferrone Expression in Anemic Rheumatoid Arthritis Patients: Is It Disordered Iron Trafficking or Disease Activity?

Youssef, S. R., Hassan, E. H., Morad, C. S., Elged, A. A. E., & El‐Gamal, R. A. E. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s327465 · Cited by 8

Effect of stimulated erythropoiesis on liver SMAD signaling pathway in iron-overloaded and iron-deficient mice

Frýdlová, J., Rogalsky, D. W., Truksa, J., Nečas, E., Vokurka, M., & Krijt, J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215028 · Cited by 7

Sevuparin strongly reduces hepcidin expression in cells, mice, and healthy human volunteers

Asperti, M., Denardo, A., Gryzik, M., Persson, K. E. M., Westerberg, G., Öhd, J., & Poli, M. (2024) · HemaSphere · doi:10.1002/hem3.70035 · Cited by 7

HIF2α, Hepcidin and their crosstalk as tumour-promoting signalling

Formica, V., Riondino, S., Morelli, C., Guerriero, S., D’Amore, F., Grazia, A. D., Blanco, G. D. V., Sica, G. S., Arkenau, H., Monteleone, G., et al. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02266-2 · Cited by 8

Regulators impeding erythropoiesis following iron supplementation in a clinically relevant rat model of iron deficiency anemia with inflammation

Ham, S. Y., Jun, J. H., Kim, H.-B., Shim, J., Lee, G., & Kwak, Y. L. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121124 · Cited by 7

Does Hepcidin Tuning Have a Role among Emerging Treatments for Thalassemia?

Longo, F., & Piga, A. G. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11175119 · Cited by 8

Modulators of the hepcidin pathway in polycythemia vera and myelofibrosis

Kremyanskaya, M., Ginzburg, Y. Z., & Hoffman, R. (2025) · Blood · doi:10.1182/blood.2025028643 · Cited by 7

Characterization of acquired anemia in children by iron metabolism parameters

Ben‐David, Y., Koren, A., Colodner, R., & Levin, C. (2022) · Scientific Reports · doi:10.1038/s41598-022-06574-0 · Cited by 6

Can molecular markers of oxygen homeostasis and the measurement of tissue oxygen be leveraged to optimize red blood cell transfusions?

Baek, J. H., & Buehler, P. W. (2019) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000533 · Cited by 5

Characterization of Erythroferrone in a Teleost Fish (Dicentrarchus labrax) With Two Functional Hepcidin Types: More Than an Erythroid Regulator

Neves, J. V., Barroso, C., Carvalho, P., Nunes, M., Gonçalves, G. S., & Rodrigues, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.867630 · Cited by 6

Differentiating iron-loading anemias using a newly developed and analytically validated ELISA for human serum erythroferrone

Diepeveen, L. E., Roelofs, R., Grebenchtchikov, N. I., van Swelm, R. P. L., Kautz, L., & Swinkels, D. W. (2021) · PLoS ONE · doi:10.1371/journal.pone.0254851 · Cited by 6

Serum erythroferrone diagnostic value in patients with beta-thalassemia with iron overload

Saeed, A. M., Nabil, N., Elsalakawy, W. A., Metwali, R., Khattab, A., & Naguib, M. G. (2021) · The Egyptian Journal of Haematology · doi:10.4103/ejh.ejh_22_21 · Cited by 5

The secreted BMP antagonist ERFE is required for the development of a functional circulatory system in Xenopus

Melchert, J., Henningfeld, K. A., Richts, S., Lingner, T., Jonigk, D. D., & Pieler, T. (2019) · Developmental Biology · doi:10.1016/j.ydbio.2019.12.007 · Cited by 5

Hepcidin: looking back at two decades of progress

Ganz, T. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00034-8 · Cited by 5

Iron Deficiency Anemia

Mettananda, S., & Athapathu, A. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15717-2.00028-7 · Cited by 5

Practical implications of the 2019 Nobel Prize in Physiology or Medicine: from molecular adaptation to hypoxia to novel anti-anemic drugs in the clinic

Busti, F., Marchi, G., Vianello, A., & Girelli, D. (2020) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02417-w · Cited by 5

Effect of Erythropoietin on the Expression of Murine Transferrin Receptor 2

Berezovsky, B., Báječný, M., Frýdlová, J., Gurieva, I., Rogalsky, D. W., Přikryl, P., Pospíšil, V., Nečas, E., Vokurka, M., & Krijt, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158209 · Cited by 5

A Decrease in Maternal Iron Levels Is the Predominant Factor Suppressing Hepcidin during Pregnancy in Mice

Helman, S. L., Wilkins, S. J., Chan, J. C. J., Härtel, G., Wallace, D. F., Anderson, G. J., & Frazer, D. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814379 · Cited by 5

Transgenic augmentation of erythroferrone in mice ameliorates anemia in adenine-induced chronic kidney disease

Czaya, B. A., Olivera, J. D., Zhang, M., Lundin, A., Castro, C. D., Jung, G., Hanudel, M. R., Nemeth, E., & Ganz, T. (2025) · JCI Insight · doi:10.1172/jci.insight.190018 · Cited by 4

Anemia of critical illness: a narrative review

Czempik, P. F., & Krzych, Ł. J. (2022) · Acta Haematologica Polonica · doi:10.5603/ahp.a2022.0016 · Cited by 7

The role of extracellular vesicles on the occurrence of clinical complications in β-thalassemia

Abdolalian, M., Zarif, M. N., & Javan, M. R. (2023) · Experimental Hematology · doi:10.1016/j.exphem.2023.08.009 · Cited by 4

Metabolic landscape and rewiring in normal hematopoiesis, leukemia and aging

Fang, H., Yu, E., Liu, C., Eapen, C., Cheng, C., & Hu, T. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.02.003 · Cited by 5

Iron Metabolism and Related Disorders

Ginzburg, Y. Z., & Finberg, K. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-812535-9.00012-1 · Cited by 4

Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice

Nai, A., Rubio, A., Campanella, A., Gourbeyre, O., Artuso, I., Bordini, J., Gineste, A., Latour, C., Besson-Fournier, C., Lin, H. Y., et al. (2016) · Blood · doi:10.1182/blood-2015-11-681494 · Cited by 97

Inactivation of Tmprss6 Hampers Hepcidin Inhibition By Erythroferrone through Upregulation of the BMP-SMAD Pathway

Silvestri, L., Nai, A., Campanella, A., Artuso, I., Bordini, J., & Camaschella, C. (2015) · Blood · doi:10.1182/blood.v126.23.408.408

Erythroferrone lowers hepcidin by sequestering BMP2/6 heterodimer from binding to the BMP type I receptor ALK3

Wang, C., Xu, Y., Traeger, L., Dogan, D. Y., Xiao, X., Steinbicker, A. U., & Babitt, J. L. (2019) · Blood · doi:10.1182/blood.2019002620 · Cited by 100

Iron, erythropoietin, and inflammation regulate hepcidin in Bmp2‐deficient mice, but serum iron fails to induce hepcidin in Bmp6‐deficient mice

Wang, C., Canali, S., Bayer, A. L., Dev, S., Agarwal, A., & Babitt, J. L. (2018) · American Journal of Hematology · doi:10.1002/ajh.25366 · Cited by 33

Erythropoietin's inhibiting impact on hepcidin expression occurs indirectly

Gammella, E., Diaz, V., Recalcati, S., Buratti, P., Samaja, M., Dey, S., Noguchi, C. T., Gassmann, M., & Cairo, G. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00410.2014 · Cited by 59